Oral Oncology
Volume 46, Issue 6 , Pages 426-428 , June 2010

Second primary tumours in oral cancer

  • Isaäc van der Waal

      Affiliations

    • VU University Medical Center (VUmc), Academic Centre for Dentistry Amsterdam (ACTA), Department of Oral and Maxillofacial Surgery/Pathology, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: VU University Medical Center (VUmc), Academic Centre for Dentistry Amsterdam (ACTA), Department of Oral and Maxillofacial Surgery/Pathology, P.O. Box 7057, 1007MB Amsterdam, The Netherlands. Tel.: +31 20 444 4039; fax: +31 20 444 4046.
  • ,
  • Remco de Bree

      Affiliations

    • VU University Medical Center (VUmc), Department of Otolaryngology/Head and Neck Surgery, The Netherlands

References 

  1. Slaughter DP, Southwick HW, Smejkal W. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer. 1953;6:963–968
  2. Van der Haring IS, Schaapveld MS, Roodenburg JLN, de Bock GH. Second primary tumours after a squamous cell carcinoma of the oral cavity or oropharynx using the cumulative incidence method. Int J Oral Maxillofac Surg. 2009;38:332–338
  3. Billroth Th. Die Allgemeine Chirurgische Pathologie und Therapie. 8e Aufl. ed. Berlin: G. Reimer; 1869.
  4. Warren S, Gates O. Multiple primary malignant tumors survey of the literature and a statistical study. Am J Cancer. 1932;16:1358–1403
  5. Geurts TW, Nederlof PM, Van den Brekel MW, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?. Clin Cancer Res. 2005;11:6608–6614
  6. Van Zeeburg HJ, Snijders PJ, Wu T, et al. Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst. 2008;100:1649–1653
  7. Farhadieh RD, Otahal P, Rees CGG, Salardini A, Russell P, Smee R. Radiotherapy is not associated with an increased rate of second primary tumours in oral squamous carcinoma: a study of 370 patients. Oral Oncol. 2009;45:941–945
  8. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol. 2002;161:1051–1060
  9. Braakhuis BJM, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck. 2002;24:198–206
  10. De Vries N, van der Waal I, Snow GB. Multiple primary tumours in oral cancer. Int J Oral Maxillofac Surg. 1986;15:85–87
  11. Dhooge IJ, De Vos M, Van Cauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope. 1998;108:250–256
  12. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck. 1999;21:204–210
  13. Levi F, Te VC, Randimbison L, Maspoli M, La VC. Second primary oral and pharyngeal cancers in subjects diagnosed with oral and pharyngeal cancer. Int J Cancer. 2006;119:2702–2704
  14. Friedrich RE. Primary and second primary cancer in 649 patients with malignancies of the maxillofacial region. Anticancer Res. 2007;27:1805–1818
  15. Rennemo E, Zatterstrom U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2063 cases. Laryngoscope. 2008;118:1350–1356
  16. Houghton DJ, Hughes ML, Garvey C, et al. Role of chest CT scanning in the management of patients presenting with head and neck cancer. Head Neck. 1998;20:614–618
  17. Strobel K, Haerle SK, Stoeckli SJ, et al. Head and neck squamous cell carcinoma (HNSCC)–detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging. 2009;36:919–927
  18. Senft A, de BR, Hoekstra OS, et al. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial. Radiother Oncol. 2008;87:221–229
  19. Bhattacharyya N, Nayak VK. Survival outcomes for second primary head and neck cancer: a matched analysis. Otolaryngol Head Neck Surg. 2005;132:63–68
  20. Alvarez Marcos CA, Llorente Pendás JL, Franco Gutiérrez V, et al. Second primary tumors in head and neck cancer. Acta Otolaryngol Esp. 2006;57:462–466
  21. Kasperts N, Slotman BJ, Leemans CR, de BR, Doornaert P, Langendijk JA. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma. Cancer. 2006;106:1536–1547
  22. Bongers V, Snow GB, de Vries N, et al. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor. Lab Invest. 1995;73:503–510
  23. Gallo O, Bianchi S. P53 Expression: a potential biomarker for risk of multiple primary malignancies in the upper aerodigestive tract. Eur J Cancer B Oral Oncol. 1995;31:53–57
  24. De Vries N, Pastorino U, Van Zandwijk N. Chemoprevention of second primary tumours in head and neck cancer in Europe: EUROSCAN. Eur J Cancer B Oral Oncol. 1994;30B:367–368
  25. Rusthoven K, Chen C, Raben D, Kavanagh B. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. Int J Radiat Oncol Biol Phys. 2008;71:192–198
  26. Rachmat L, Vreeburg GC, de Vries N, et al. The value of twice yearly bronchoscopy in the work-up and follow-up of patients with laryngeal cancer. Eur J Cancer. 1993;29A:1096–1099
  27. Kesting MR, Robitzky L, Al-Benna S, et al. Bronchoscopy screening in primary oral squamous cell carcinoma: a 10-year experience. Br J Oral Maxillofacial Surg. 2009;47:279–283
  28. Hujala K, Sipila J, Grenman R. Panendoscopy and synchronous second primary tumors in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2005;262:17–20

PII: S1368-8375(10)00065-5

doi: 10.1016/j.oraloncology.2010.02.018

Oral Oncology
Volume 46, Issue 6 , Pages 426-428 , June 2010